Trial Profile
Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 06 Nov 2015 New trial record